Tag Archives: First

Is Empathy Born in Mom’s First Hugs?

MONDAY, April 5, 2021 — Show your baby your love, and you’ll get a kinder, gentler adult child as your reward, a new study suggests. More than 20 years ago, researchers in Israel began studying the impact on newborns of time spent in physical contact with their mothers. The investigators followed these infants, born in… Read More »

NI CMO receives first dose of AstraZeneca vaccine

Northern Ireland’s Chief Medical Officer (CMO), Dr Michael McBride has received his first AstraZeneca vaccine shot today, despite European countries halting its administration. The CMO told reporters that he was “delighted to get the AstraZeneca vaccine this morning” and “welcomed the opportunity,” this morning. Northern Ireland First Minister and DUP leader Arlene Foster is due… Read More »

North Carolina bars allowed to open indoors for first time since March 2020

Bars in North Carolina will be able to conduct business indoors for the first time since March 2020 following a new executive order from Gov. Roy Cooper. Cooper announced on Wednesday that he was loosening a modified stay-at-home order he imposed in December and then extended in late January in response to rising COVID-19 cases… Read More »

World’s first tradable carbon token is set to democratize access to the most important new asset class for generations

Universal Carbon [UPCO2] is the world’s first retail-accessible carbon credit token. Each Token represents one year-tonne of CO2 or equivalent reductions from certified REDD+ voluntary projects in the world’s rainforests. Available on Uphold now to trade, or to offset carbon footprints. NEW YORK – December 1, 2020 The Universal Protocol Alliance (UPA), a coalition of… Read More »

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma

PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 360 mg every three weeks plus Yervoy (ipilimumab) 1 mg/kg every six weeks (injections for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the first-line treatment of adult patients with unresectable malignant pleural… Read More »